Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04600115 · ClinicalTrials.gov registry record · Early Phase 1
New MRI Methods Applied to Heart Failure With Preserved Ejection Fraction (HFpEF)
A Early Phase 1 study, sponsored by University of Utah.
- Recruiting
- Registry status
- Early Phase 1
- Development phase
- 100
- Enrollment target
NCT04600115 is a Early Phase 1 study that is actively recruiting participants, run by University of Utah. The registered enrollment target is 100 participants.
The verdict
NCT04600115, a Early Phase 1 study, is actively recruiting participants, sponsored by University of Utah.
- RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 100 participants
- Enrollment target
Study Summary
This study's main specific aims are; 1. To develop robust acquisition and reconstruction methods specifically for the study of microvascular cardiac remodeling with MRI which will include very innovative quantitative perfusion methods, as well as fibrosis quantification, longitudinal strain, and phase contrast imaging for flow. 2. Test the new methods for identifying the clinical task of characterizing HFpEF.
Interventions
- DEVICE MRI
- DRUG Regadenoson
- DRUG Adenosine
- DRUG O-15 labeled radioactive water
- DEVICE PET Imaging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2017-03-03 |
| Est. Completion | 2027-03-03 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04600115
The ClinicalTrials.gov registry entry for NCT04600115 describes a study currently listed as recruiting, categorized as Early Phase 1. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Utah, which has 818 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which MRI is the first listed.
NCT04600115 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04600115 about?
NCT04600115 is a clinical study titled "New MRI Methods Applied to Heart Failure With Preserved Ejection Fraction (HFpEF)". This study's main specific aims are; 1. To develop robust acquisition and reconstruction methods specifically for the study of microvascular cardiac remodeling with MRI which will include very innovative quantitative perfusion methods, as well as fibrosis quantification, longitudinal strain, and ph...
What is the current status of trial NCT04600115?
This trial is currently recruiting. It is a Early Phase 1 study. The enrollment target is 100 participants. The study started on 2017-03-03. Estimated completion is 2027-03-03.
What interventions are being tested in trial NCT04600115?
The interventions under investigation include: MRI (DEVICE), Regadenoson (DRUG), Adenosine (DRUG), O-15 labeled radioactive water (DRUG), PET Imaging (DEVICE).
Who is sponsoring clinical trial NCT04600115?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.